X4 Pharmaceuticals's total assets for Q1 2025 were $130.01M, a decrease of -11.22% from the previous quarter. DE:48Q total liabilities were $107.07M for the fiscal quarter, a -13.86% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.